Sources of Research Material - University of Colorado Boulder

advertisement

Adult General Clinical Research Center

University of Colorado Health Sciences Center

National Jewish Center Satellite

University of Colorado Boulder Satellite

Protocol Application

Date Submitted:

Title:

Protocol Number

(This will be assigned by the

GCRC at the initial review)

Name Academic Rank Department / Division Phone

Number

Campus

Box

Principal Investigator:

Co-Investigators:

Contact Person:

I agree to provide all information requested by the GCRC in a timely manner. Information will be requested on a yearly basis to satisfy NIH reporting requirements.

Signature of Principal Investigator

(my typed name indicates agreement with the above statement)

_____________________________________________________________________________

Human Subjects (COMIRB) Status : pending approved # Date approved

Type of Study : Category A Study - Visits will be for research purposes ONLY - Investigator-Initiated

Category B Study - Visits will be for Research Service Patients

Category D Study - Visits will be for an Industry-Initiated study - All 'D' studies must provide the industry-approved budget and three copies of the industry protocol with this application

Research Area :

Select Here Other (if not in list):

General Utilization Information

Is this study: Inpatient Outpatient Both Inpatient & Outpatient

How many subjects do you plan to enroll at the GCRC?

If this is a multi-center trial, how many total subjects will be enrolled?

What will be the estimated duration of the study, in years?

Important note : If cutting and pasting from other documents, remove all page breaks or section breaks from originals first.

Breaks pasted in from originals prevent you from editing this form afterward. (questions, call Tom Yaeger 372-8803)

Title:

I.

Hypothesis and Specific Aims

Hypothesis:

2

Specific Aims:

II.

Background and Significance

III.

Progress Report / Preliminary Studies

IV.

Research Design and Methods

Sample Size Justification and Analysis Plan

V.

Human Subjects

Description of Study Population

Sources of Research Material

Subject Recruitment and Consent Procedures

Potential Risks and Alternative Treatments

Procedures for Minimizing Risks

Risk/Benefit Analysis

VI.

Gender and Ethnicity Tables

Table 1 National Demographics for the Study Population (in percentages)

American Indian or Alaskan

Native

Female

Male

Unknown

Total

Source:

Asian or

Pacific

Islander

Black, not of

Hispanic Origin

Hispanic White, not of

Hispanic Origin

Other or

Unknown

Total

100%

Table 2 Local Demographics for the Study Population (in percentages)

Female

Male

Unknown

Total

Source:

American

Indian or

Alaskan Native

Asian or

Pacific

Islander

Black, not of

Hispanic Origin

Hispanic White, not of

Hispanic Origin

Other or

Unknown

Total

100%

Table 3 Expected Distribution for this Study ( in numbers of subjects)

Female

Male

Unknown

Total

American

Indian or

Alaskan Native

Asian or

Pacific

Islander

Black, not of

Hispanic Origin

Hispanic White, not of

Hispanic Origin

Other or

Unknown

Total

VII.

Justification for Utilization of GCRC Resources

3

VIII.

Bibliography

Important note: Remove all page breaks or section breaks from original before pasting. Breaks pasted in from original prevent you from editing form afterward. (questions; call Tom Yaeger 372-8803)

Consent Form see important notice above (Insert here.)

One Year Projected Utilization of the GCRC

How many subjects do you plan on enrolling in Year 1 of your study?

A.

SCREENING VISITS

1.

Total number of subjects you will screen per year

2.

Number of screening visits per patient

3.

Approximate length of screening visits (hours)

B.

OUTPATIENT CLINIC VISITS

C.

1.

Total number of subjects to be seen per year

2.

Total number of outpatient visits per subject ( do not include screening visits)

3.

Length of outpatient clinic visits

SHORT STAYS ON THE INPATIENT UNIT (The subjects will not stay over night)

**These stays will be counted as outpatient visits .

1.

Indicate the total number of subjects to be seen per year

2.

Total number of inpatient admissions per subject

3.

Length of stay

4.

Research nursing services requested (please check)

Phlebotomy Yes No

D.

RMR

Exercise Testing

IVGTT

Euglycemic Clamp

Other

Yes

Yes

Yes

Yes

No

No

No

No

If yes, # per patient

If yes, # per patient

INPATIENT ADMISSIONS (The subjects will have an overnight stay)

4

1.

Indicate the number of subjects to be admitted per year

2.

Total number of inpatient admissions per subject

3.

Length of each inpatient stay (please check)

1 day 2 days 3 days 4 days 5 days other

4.

Research nursing services requested (please check)

Yes No Phlebotomy

RMR

Exercise Testing

IVGTT

Euglycemic Clamp

Yes

Yes

Yes

Yes

No

No

No

No

If yes, # per patient

If yes, # per patient

Other

E.

DIETARY SERVICES

– (Available at the University of Colorado Health Sciences Center)

If you are requesting any dietary support including inpatient/outpatient meals, please complete the following.

1.

Meals Requested : Inpatient Outpatient

Will any meals be packed out?

Calorimetry Room, # of days:

Yes No

Are meals to be served at specific times?

2.

Other Services

Yes No

Please check any other services requested:

Diet History :

24 Hr Recall

Research Diet Instruction :

Test Meals :

Patient

3-day Food Record

Family/Spouse

Food Frequency

Check here if provided by GCRC Specify meal:

3.

Special Diets/Requests :

F.

ANCILLARY REQUESTS – YEAR ONE

List only those ancillary costs that you are requesting to be paid by the GCRC. Distribution of ancillary funds is at the discretion of the Scientific Advisory Committee.

1.

Request for Laboratory Tests Please list the total number of tests to be run in Year 1 on an inpatient and outpatient basis. List tests separately. (While working in the table depress the tab key from within the last cell to add new row)

Laboratory Name Test Name Total # tests per year

Inpatient Outpatient &

Short Stays on I/P Unit

2.

Request for Sample Processing (i.e. Processing for laboratories other than the GCRC Core Lab)

UCHSC For the Drug Company

Indicate the # of samples per patient

5

Are you requesting long term storage (> 2 months)? Yes No

3.

Other Ancillary Requests: Please list any other ancillary support you are requesting (i.e.,EKG’s, xrays).

(While working in the table depress the tab key from within the last cell to add new row)

Ancillary Department Service Requested Total # per year

Inpatient Outpatient &

Short Stays on I/P Unit

G.

INFORMATICS & COMPUTER SUPPORT

(some services only available at the University of Colorado

Health Sciences Center)

Please check the following Informatics services that you are requesting (all are free of charge for category 'A' studies):

Data management - this includes assistance with data quality and preparing data for analysis

Data storage on the GCRC Server/ Computer system - offers daily backup and data security

Custom database designed for the input and analysis of all data collected in your study

Use of GCRC Computer Equipment

Computer & Laser printer on the unit CD ROM for archiving data Scanner

Statistical software - installation, licensing, and support of SAS and/or JMP (if you already have a license for either program through the GCRC and plan to use it for this study, please check this box)

Results from our Core Laboratory electronically downloaded to you for access from your office PC

H.

BIOSTATISTICAL SUPPORT

Did you consult the GCRC Biostatistician during the design of your research protocol?

If it were available, would you request assistance with the analysis of your study data?

I.

BRIEF SUMMARY (in layperson’s language)

Yes No

Yes No

J.

AXIS CODES

Check off at least one Axis Code for each of the three sections. You may select up to six codes for each Axis.

Axis I: Resource Material

2

3

4

5a

5b

5c

5d

6

7a

1a

1b

1c

1d

1e

1f

Animals (Whole): Vertebrates, Mammal

Animals (Whole): Vertebrates, Non-Mammal

Animals (Whole): Invertebrates

Animals (Cell-Org): Vertebrates, Mammal

Animals (Cell-Org): Vertebrates, Non-Mammal

Animals (Cell-Org): Invertebrates

Biological/Chemical Compounds

Biomaterials

Human, Cells Only

Human, Adult, Female

Human, Adult, Male

Human, Infant/Child, Female

Human, Infant/Child, Male

Membrane/Tissue/Isolated Organ

Microorganisms – Bacteria

7b

7c

7d

8

Microorganisms – Virus

Microorganisms – Parasites

Microorganisms – Other

Plants, Fungi

9

11

Technology/Technique Development

Facility Construction/Improvement

12a Clinical Trials – Multicenter

16d

16e

16f

17

18

19

20

21

22

13

14

15

16a

16b

16c

23

24

25a

25b

25c

25d

26

Axis I: Anatomical Systems

Cardiovascular System

Connective Tissue

Endocrine System

Gastrointestinal System – Esophagus

Gastrointestinal System – Gallbladder

Gastrointestinal System – Intestine

Gastrointestinal System – Liver

Gastrointestinal System – Pancreas

Gastrointestinal System - Stomach

Hematological System

Integumentary/Skin System

Lymphatic and Reticulo-Endothelial System

Muscular System

Nervous System

Oral/Dental

Reproductive System

Respiratory System

Sensory System – Ear

Sensory System – Eye

Sensory System – Taste/Smell

Sensory System – Touch

Skeletal System

12b Clinical Trials – Single Center

12c Clinical Trials – Phase I

12d Clinical Trials – Phase I & II

12e Clinical Trials – Phase II

12f Clinical Trials – Phase II & III

12g Clinical Trials – Phase III

12h Clinical Trials – Phase III & IV

12i Clinical Trials – Phase IV

36

38

39

40

41

42

44

30

31

32

33

34

35

Aging

AIDS, SAIDS, HIV, SIV

Anesthesiology

Alternative Medicine

Anthropology/Ethnography

Arthritis

Behavior/Psychology/Social Science

Bioethics

Biotechnology (rDNA, cDNA, Hybridoma

Communication/Speech

Cognition/Learning

Computer Science

Congenital Defects or Malformation

45

46

48

49

Deafness/Hearing

Degenerative Disorders

Device/Prostheses, Intra/Extracorporeal

Diabetes

50a Drug/Therapeutic Agent Studies: Toxic

50b Drug/Therapeutic Agent Studies: Other

50c Drug/Therapeutic Agent Studies: Orphan

Drugs

51 Education

52 Engineering/Bioengineering

54a Environmental Sciences – Toxic Substances

54b Environmental Sciences – Other

55

56

57

58

59

Gene Therapy

Epidemiology

Fitness, Physical

Genetics, Including Metabolic Errors

Genome

27

28

Axis II : Research Area

60 Growth and Development

62 Health Care Applications

63a Imaging: CT

63b Imaging: Laser

63c Imaging: MRI, MRS

63d Imaging: NMR

63e Imaging: PET

63f Imaging: Spect

63g Imaging: Radiography

63h Imaging: Ultrasound

63I Imaging: Microscopy

63j Imaging: Near Infrared

64 Immunology and Allergy

65 Infant Mortality

66 Infectious Diseases

67 Nursing Care Research

68 Information Science

69 International Health

70 Instrument Development

71 Maternal and Child Health

Urinary System

Other (Specify)

82

83

84

85

86

87

88

74h Metabolism: Protein & Amino Acid

75a Minority Health: Asian/Pacific Islanders

75b Minority Health: Blacks

75c Minority Health: Hispanics

75d Minority Health: Native Americans

75e Minority Health: Other

76a Neoplasm/Oncology/Cancer - Benign

76b Neoplasm/Oncology/Cancer – Malignant

77 Model Development

78

79

80

81

Nutrition

Pain

Radiology/Radiation/Nuclear Medicine

Rare Disease

Rehabilitation

Sexually Transmitted Disease

Statistics/Mathematics

Sleep Research

Surgery

Substance Abuse

Transplantation

72 Mental Disorders/Psychiatry

73

Men’s Health

74a Metabolism: Carbohydrate

74b Metabolism: Electrolyte/Mineral

74c Metabolism: Enzymes

74d Metabolism: Gases

74e Metabolism: Hormone

74f Metabolism: Lipid

74g Metabolism: Nucleic Acid

89

90

91

92

93

94

95

Structural Biology

Trauma/Burns/Injury

Vaccine

Other (SPECIFY)

Women’s Health Research

Prevention

Transgenics

K.

FUNDING SUPPORT

You will need to provide information on all grant support for the PI and each Co-I listed on this protocol.

You can do this by copying and pasting NIH other support pages below.

Please do the following:

1.

List the grant(s) that support(s) this GCRC protocol here:

2.

Copy and paste your NIH other support pages for the PI and all Co-I’s here:.

6

Download